Echocardiographic abnormalities in children and adolescents living with human immunodeficiency virus on highly active antiretroviral treatment

被引:0
|
作者
Wubayehu, Tewolde [1 ]
Abebe, Workeabeba [2 ]
Tefera, Endale [3 ]
机构
[1] Aksum Univ, Dept Paediat & Child Hlth, Aksum, Ethiopia
[2] Addis Ababa Univ, Sch Med, Dept Paediat & Child Hlth, Div Infect Dis, Addis Ababa, Ethiopia
[3] Univ Botswana, Fac Med, Dept Paediat & Adolescent Hlth, Div Cardiol, Gaborone, Botswana
基金
英国医学研究理事会;
关键词
echocardiographic abnormalities; HIV-infected children; cardiac involvement; myocardial mass index; tissue Doppler imaging; HIV-INFECTED CHILDREN; MYOCARDIAL PERFORMANCE INDEX; TISSUE DOPPLER VELOCITIES; CHAMBER QUANTIFICATION; EUROPEAN-ASSOCIATION; AMERICAN-SOCIETY; HEART-DISEASE; THERAPY; RECOMMENDATIONS; INVOLVEMENT;
D O I
10.5830/CVJA-2019-072
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: The availability and use of highly active antiretroviral treatment (HAART) has turned human immunodeficiency virus (HIV) into a chronic disease, allowing patients to live much longer. Objectives: To report asymptomatic cardiac abnormalities in children and adolescents based on both conventional and tissue Doppler imagine (TDI) echocardiography. Methods: One hundred and fifty-one patients on HAART were recruited. Demographic and clinical variables were collected through patient interviews and medical record reviews. Conventional echocardiography and TDI were performed on each patient. Results: Mean age wets 13.0 +/- 3.2 (4.0-19.0) years Eighty-three patients (55%) were female. Age at diagnosis of HIV infection was 5.7 +/- 3.3 years. Age at initiation of HAART was 7.34 +/- 3.54 years, while duration of HAART was 59 +/- 39.1 months. On conventional echocardiography, three cases of left ventricular (LV) systolic dysfunction, two of pulmonary hypertension and one of minimal pericardial effusion were identified. Calculation of myocardial mass index (MMI) revealed that 16 patients had abnormal values. Twenty-seven (17.9%) patients had evidence of LV diastolic dysfunction and 18 (11.9%) had right ventricular (RV) diastolic dysfunction. Nineteen (12.6%) patients had tricuspid annular systolic velocity of < 9.5 cm/s, indicating asymptomatic RV systolic dysfunction. Conclusion: While few patients had abnormalities such as reduced IN ejection fraction, pulmonary hypertension and minimal pericardial effusion detectable on conventional echocardiography, a larger proportion of patients had subtle abnormalities such as increased MMI, LV diastolic dysfunction on TDL RV dysfunction and abnormal myocardial performance index. Such patients may need routine screening and cardiac follow up.
引用
收藏
页码:236 / 240
页数:5
相关论文
共 50 条
  • [1] Incidence and Progression of Echocardiographic Abnormalities in Older Children with Human Immunodeficiency Virus and Adolescents Taking Antiretroviral Therapy: A Prospective Cohort Study
    Majonga, Edith D.
    Rehman, Andrea M.
    Mchugh, Grace
    Mujuru, Hilda A.
    Nathoo, Kusum
    Odland, Jon O.
    Ferrand, Rashida A.
    Kaski, Juan Pablo
    [J]. CLINICAL INFECTIOUS DISEASES, 2020, 70 (07) : 1372 - 1378
  • [2] Highly active antiretroviral therapy and human immunodeficiency virus encephalitis
    Cook, JE
    Dasgupta, S
    Middaugh, LD
    Terry, EC
    Gorry, PR
    Wesselingh, SL
    Tyor, WR
    [J]. ANNALS OF NEUROLOGY, 2005, 57 (06) : 795 - 803
  • [3] Dermatological aspects of medicine: highly active antiretroviral therapy and the treatment of human immunodeficiency virus
    Finucane, K. A.
    Archer, C. B.
    [J]. CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2010, 35 (01) : 107 - 109
  • [4] Effect of highly active antiretroviral therapy on cardiovascular involvement in children with human immunodeficiency virus infection
    Plebani, A
    Esposito, S
    Pinzani, R
    Fesslova, V
    Bojanin, J
    Salice, P
    Rossi, M
    Principi, N
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2004, 23 (06) : 559 - 563
  • [5] Growth of human immunodeficiency virus-infected children receiving highly active antiretroviral therapy
    Nachman, SA
    Lindsey, JC
    Moye, J
    Stanley, KE
    Johnson, GM
    Krogstad, PA
    Wiznia, AA
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2005, 24 (04) : 352 - 357
  • [6] Physical Fitness in Children Infected with the Human Immunodeficiency Virus: Associations with Highly Active Antiretroviral Therapy
    Somarriba, Gabriel
    Lopez-Mitnik, Gabriela
    Ludwig, David A.
    Neri, Daniela
    Schaefer, Natasha
    Lipshultz, Steven E.
    Scott, Gwendolyn B.
    Miller, Tracie L.
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 2013, 29 (01) : 112 - 120
  • [7] Oral manifestations in human immunodeficiency virus infected children in highly active antiretroviral therapy era
    Pinheiro, Raquel dos Santos
    Franca, Talita Tenorio
    Beder Ribeiro, Camila Maria
    Leao, Jair Carneiro
    Ribeiro de Souza, Ivete Pomarico
    Castro, Gloria Fernanda
    [J]. JOURNAL OF ORAL PATHOLOGY & MEDICINE, 2009, 38 (08) : 613 - 622
  • [8] Highly active antiretroviral therapy (HAART) for the treatment of infection with human immunodeficiency virus type 1
    Shafer, RW
    Vuitton, DA
    [J]. BIOMEDICINE & PHARMACOTHERAPY, 1999, 53 (02) : 73 - 86
  • [9] Pediatric Human Immunodeficiency Virus infection and cancer in the Highly Active Antiretroviral Treatment (HAART) era
    Chiappini, Elena
    Berti, Elettra
    Gianesin, Ketty
    Petrara, Maria Raffaella
    Galli, Luisa
    Giaquinto, Carlo
    de Martino, Maurizio
    De Rossi, Anita
    [J]. CANCER LETTERS, 2014, 347 (01) : 38 - 45
  • [10] Human immunodeficiency virus infection. Part III. Antiretroviral treatment for children and adolescents
    [J]. REVISTA CHILENA DE INFECTOLOGIA, 2010, 27 (05): : 449 - 474